IHC-P analysis of liver carcinoma tissue using GTX84062 NAT8 antibody [6H3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

ICC/IF analysis of COS7 cells transiently transfected with NAT8 plasmid using GTX84062 NAT8 antibody [6H3].

IHC-P analysis of breast adenocarcinoma tissue using GTX84062 NAT8 antibody [6H3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

IHC-P analysis of colon adenocarcinoma tissue using GTX84062 NAT8 antibody [6H3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

IHC-P analysis of lung carcinoma tissue using GTX84062 NAT8 antibody [6H3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

IHC-P analysis of human ovary adenocarcinoma tissue using GTX84062 NAT8 antibody [6H3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

IHC-P analysis of thyroid carcinoma tissue using GTX84062 NAT8 antibody [6H3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

IHC-P analysis of prostate carcinoma tissue using GTX84062 NAT8 antibody [6H3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

IHC-P analysis of kidney carcinoma tissue using GTX84062 NAT8 antibody [6H3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

WB analysis of HEK293T cells transfected with NAT8 plasmid (Right) or empty vector (Left) for 48 hrs using GTX84062 NAT8 antibody [6H3].
Loading : 5 ug per lane

IHC-P analysis of bladder carcinoma tissue using GTX84062 NAT8 antibody [6H3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50